ACRS Q1 2022 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q1 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1M-18.2% YoY

Gross Profit

$298,00020.5% margin

Operating Income

-$19M-1301.2% margin

Net Income

-$19M-1293.1% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$227M

Total Liabilities

$46M

Stockholders' Equity

$180M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-18.2%
Gross Profit	$298,000	$575,000	-48.2%
Operating Income	-$19M	-$29M	+33.7%
Net Income	-$19M	-$29M	+34.7%

Revenue Segments

Contract research

$1M84%

Other revenue

$232,00016%